Search Results - "Provost, Nicole"
-
1
Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease
Published in Blood (18-11-2010)“…Erdheim–Chester disease (ECD) pathophysiology remains largely unknown. Its treatment is not codified and usually disappointing. Interferon (IFN)-α therapy…”
Get full text
Journal Article -
2
A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
Published in Clinical cancer research (15-09-2009)“…Purpose: This study aimed to evaluate the safety of, immune response induced by, and efficacy of treatment with lapuleucel-T (APC8024) in patients with…”
Get full text
Journal Article -
3
Diagnostic Value of Three-Dimensional Contrast-Enhanced Echocardiography for Left Ventricular Volume and Ejection Fraction Measurement in Patients With Poor Acoustic Windows: A Comparison of Echocardiography and Magnetic Resonance Imaging
Published in Journal of the American Society of Echocardiography (01-10-2014)“…Background Three-dimensional echocardiography (3DE) is a reliable and reproducible tool for assessing left ventricular (LV) function but remains sensitive to…”
Get full text
Journal Article -
4
Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer
Published in Cancer (15-08-2009)“…BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The…”
Get full text
Journal Article -
5
Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease
Published in Journal of cardiovascular magnetic resonance (19-01-2013)“…Coronary artery disease (CAD) patients are at risk for life-threatening ventricular arrhythmias (VA) related to scar tissue. Late gadolinium enhancement…”
Get full text
Journal Article -
6
Abstract 5608: Sipuleucel-T treatment results in sequential ex vivo activation of APCs and T cells during the culture step - evidence for in vivo immunological priming
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Introduction. Sipuleucel-T is an investigational autologous immunotherapy for the treatment of prostate cancer. Product potency is measured in part by…”
Get full text
Journal Article -
7
Abstract 2932: Sipuleucel-T generates robust and persistent cellular and humoral immune responses - Results from the IMPACT trial
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Introduction. Sipuleucel-T is a patient-specific autologous cell product consisting of antigen presenting cells (APCs) loaded with a recombinant…”
Get full text
Journal Article -
8
A Phase 1 Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
Published in Clinical cancer research (01-09-2009)Get full text
Journal Article -
9
Vive l'Archéologie
Published in Archaeology (01-05-2001)“…An exhibit of historic artifacts at the Carnavalet Museum in Paris is reviewed…”
Get full text
Book Review Magazine Article -
10
Cloning of a Drosophila melanogaster guanine nucleotide regulatory protein beta-subunit gene and characterization of its expression during development
Published in Proceedings of the National Academy of Sciences - PNAS (01-10-1988)“…A Drosophila melanogaster gene encoding a protein with >80% sequence identity to the β subunits of mammalian guanine nucleotide-binding regulatory proteins (G…”
Get full text
Journal Article